Pingli Liu
44Patents
11h-index
82Co-inventors
78Inventor score
Filing activity: Mar 5, 1999 → Feb 17, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8410265B2 | Processes for preparing JAK inhibitors and related intermediate compounds | Emerging Cross-Sectional Technologies | 112 | Active |
| US8987443B2 | Processes and intermediates for making a JAK inhibitor | Chemistry; Metallurgy | 72 | Active |
| US9487521B2 | Processes and intermediates for making a JAK inhibitor | Emerging Cross-Sectional Technologies | 66 | Active |
| US9000161B2 | Processes for preparing JAK inhibitors and related intermediate compounds | Emerging Cross-Sectional Technologies | 58 | Active |
| US8993582B2 | Processes for preparing JAK inhibitors and related intermediate compounds | Emerging Cross-Sectional Technologies | 56 | Active |
| US9290506B2 | Processes for preparing JAK inhibitors and related intermediate compounds | Emerging Cross-Sectional Technologies | 56 | Active |
| US8420645B2 | Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same | Chemistry; Metallurgy | 22 | Active |
| US10189832B2 | Crystalline solid forms of a BET inhibitor | Chemistry; Metallurgy | 17 | Active |
| US8796319B2 | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | Chemistry; Metallurgy | 14 | Active |
| US10329305B2 | Amorphous solid form of a BET protein inhibitor | Human Necessities | 14 | Active |
| US8901123B2 | Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same | Chemistry; Metallurgy | 12 | Active |
| US6376491B1 | Bicyclic compounds | Chemistry; Metallurgy | 11 | Expired |
| US6300353A | Azoles for treatment of fungal infections | Chemistry; Metallurgy | 11 | Expired |
| US10626114B2 | Crystalline solid forms of a BET inhibitor | Chemistry; Metallurgy | 10 | Active |
| US9718834B2 | Processes and intermediates for making a JAK inhibitor | Emerging Cross-Sectional Technologies | 9 | Active |
| US10858372B2 | Amorphous solid form of a BET protein inhibitor | Human Necessities | 8 | Active |
| US10899736B2 | Processes and intermediates for making a JAK inhibitor | Human Necessities | 6 | Active |
| US11753406B2 | Salts of a PD-1/PD-L1 inhibitor | Chemistry; Metallurgy | 6 | Active |
| US11091480B2 | Crystalline solid forms of a BET inhibitor | Chemistry; Metallurgy | 6 | Active |
| US11760756B2 | Crystalline form of a PD-1/PD-L1 inhibitor | Chemistry; Metallurgy | 6 | Active |
| US9714233B2 | Processes and intermediates for making a JAK inhibitor | Chemistry; Metallurgy | 5 | Active |
| US11780836B2 | Process of preparing a PD-1/PD-L1 inhibitor | Chemistry; Metallurgy | 5 | Active |
| US10245265B2 | Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same | Chemistry; Metallurgy | 5 | Active |
| US11377446B2 | Crystalline solid forms of a BET inhibitor | Chemistry; Metallurgy | 4 | Active |
| US9908888B2 | Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidines | Emerging Cross-Sectional Technologies | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.